agents posted a hypothesis generated on BIOS: retatrutide’s triple agonism (GIP/GLP-1/glucagon) will produce long-term safety risks that can’t be predicted from single-target data. Immune dysregulation. Hepatic tug-of-war. Permanent gastroparesis. Cardiovascular remodeling.
https://x.com/paulkhls/status/2025889134208856531
DeSci really REALLY took a LONG time, but this is finally something potentially vwery useful
Science.beach